South Africa has a new dollar billionaire and it is Dis-Chem founder Ivan Saltzman

Ivan Saltzman, who co-founded Dis-Chem Pharmacies with his wife Lynette in 1978 from a single discount pharmacy in the Johannesburg suburb of Mondeor, has joined the ranks of South Africa's dollar billionaires for the first time, with the Bloomberg Billionaires Index valuing the Saltzman family fortune at $1.3 billion in its inaugural ranking of the family's net worth.

The Bloomberg ranking, published on June 29, 2026, arrives on the same day that Saltzman stepped back from his role as non-executive deputy chairman of Dis-Chem, completing a gradual exit from the company he spent 48 years building into one of South Africa's most recognisable retail brands. He now joins Johann Rupert and Patrice Motsepe as the South African billionaires tracked by Bloomberg's daily index, a cohort that represents the apex of wealth creation in Africa's most industrialised economy.

The Saltzman family's $1.3 billion fortune is derived primarily from its combined shareholding in Dis-Chem Pharmacies, which is listed on the Johannesburg Stock Exchange and operates more than 200 retail pharmacies and 44 baby stores across South Africa, Zimbabwe and Botswana, with a wholesale arm that services approximately 1,608 independent pharmacies representing roughly 85 percent of South Africa's independent pharmacy market. The company's market capitalisation stands at approximately $1.7 billion. Ivan and Lynette, both registered pharmacists, gifted two of their sons, Dan and Mark, significant stakes in Dis-Chem ahead of Ivan's retirement, ensuring the family retains more than a quarter of the firm across its combined holdings.

The Bloomberg ranking crystallises a wealth story that has been building for nearly five decades but has only recently been formally measured by the world's most closely watched billionaire tracking index. Bloomberg's decision to begin valuing the Saltzman family's net worth coincides with the succession process unfolding at Dis-Chem, which the index's editorial team is examining as part of a broader investigation into South Africa's generational wealth transfer, estimated to involve approximately $85 billion in high-net-worth assets over the next decade as more than 40 percent of the country's wealthy individuals, most of them over 60, begin transferring their fortunes to the next generation.

The wealth that Bloomberg is now tracking was built on a deceptively simple retail proposition. When Ivan and Lynette Saltzman opened their first pharmacy in Mondeor, the selling price of medicines in South Africa was not generally regulated. That created an opening for a discount pharmacy model to offer consumers better value than they were getting from conventional dispensaries. The Saltzmans took it. Their earliest advertising asked a deliberately provocative question: "Does the price of medicine make you sick?" It was a proposition that resonated with a South African consumer who had limited alternatives and no particular loyalty to existing pharmacy chains. The discount model worked. The store grew. Then it grew some more. By the time Dis-Chem listed on the JSE in 2016, it was already one of the most profitable pharmacy chains in the country and the listing itself was one of the most anticipated consumer retail IPOs of that year.

Lynette stepped back from her executive director role in 2022. Their son Saul, who served as an executive director for 19 years, resigned effective February 2026 in a shift to a non-executive role. Ivan served as executive director until completing his transition to non-executive deputy chairman before stepping off the board entirely. Chief Executive Rui Morais, who was appointed in 2023 after working on Dis-Chem's JSE listing, has articulated a strategy that takes the business from its pharmacy origins into integrated primary healthcare, with the store of the future format combining retail, digital health services and wellness ecosystems in a single physical and digital environment.

The Bloomberg billionaire designation is not simply symbolic. It signals that the Saltzman family's wealth is now being measured in the same global framework used to track Elon Musk, Aliko Dangote and Johann Rupert, which gives South Africa's newest dollar billionaire family visibility in capital markets and media conversations that were previously closed to them. At $1.3 billion, the family ranks well below Rupert's estimated $10.2 billion and Motsepe's $3.7 billion, but the trajectory of Dis-Chem's business, and the question of whether the Morais-led management team can sustain the growth culture the Saltzmans built, will determine where that figure goes in the years ahead.